McLoughlin Margaret

CIK 00017708231 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001770823

Recent Transactions

24 trades

Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (Right to Buy)
2026-01-02+19,547→ 19,547 total
Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (Right to Buy)
2025-06-04+27,000→ 27,000 total
Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (right to buy)
2025-01-02+31,613→ 31,613 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2024-06-05+27,000→ 27,000 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-08-08$1.23/sh+8,000→ 8,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2023-05-24+27,000→ 27,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2022-06-08+27,000→ 27,000 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2021-10-08−1,000→ 84,911 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-10-08$17.00/sh+1,000→ 1,000 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-10-08$88.93/sh−1,000→ 0 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-08-16$96.51/sh−1,429→ 471 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-08-16$97.55/sh−423→ 48 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-08-16$98.90/sh−48→ 0 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-08-16$95.57/sh−1,044→ 1,900 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2021-08-16−6,000→ 85,911 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-08-16$17.00/sh+6,000→ 6,000 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-08-16$94.55/sh−3,056→ 2,944 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-06-28$55.73/sh−100→ 0 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-06-28$55.03/sh−250→ 100 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-06-28$55.01/sh−200→ 350 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2021-06-16+11,029→ 11,029 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-06-08+11,029→ 11,029 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-05-13$17.00/sh+550→ 550 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to buy)
2019-05-08+91,911→ 91,911 total

Companies

Quince Therapeutics, Inc.
Director
$QNCX

Recent Filings

Address

C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 273

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov